ExElixis.com is a drug research and development lab located in California
Title
Exelixis-an integrated drug discovery and development company, drug research, discovery and clinical development
Description
Commercializing truly innovative therapies requires creative approaches to the drug development process. At Exelixis, innovation is everywhere, creating a new paradigm for the biotechnology industry.
A Broad and Expanding Pipeline
At Exelixis, we are committed to making a meaningful impact on the lives of patients living with cancer and other serious diseases. We are advancing an ambitious and pragmatic approach to drug development, to develop first-in-class and best-in-class therapies that will transform the treatment of cancer. We are transforming the challenges of our industry into opportunities for success by thinking larger, moving faster and charting our own course to our goal. Today we are a development-stage biotechnology company with eight compounds in clinical development with many more advancing to the clinic. As we look toward the future, we are building a portfolio of targeted compounds that modulate the activity of multiple disease-related pathways to achieve superior disease control and patient outcomes.
Leveraging the Power of Our Platform
We believe that the next generation of cancer therapies requires innovation in every part of our discovery, development and business organizations. At Exelixis, this means pursuing an uncommon approach to drug discovery and development, one that combines critical mass, speed, and unique approaches to create significant momentum toward our goals. With a library of more than 4 million compounds, we are able to rapidly identify high-quality leads for new drugs. Our extensive abilities in structure-based design and our approaches to pharmacodynamics and pharmacokinetics enable us to move these leads quickly forward. These capabilities are a resource that will enable us to file at least three investigational new drug applications (IND) each year for the next several years. Even with an extensive and vigorous selection process to assure high-quality, we retained our speed, filing eight INDs in the past two years.
Contact
| Whois information is public, but in response to some people wanting to keep their contact information private, many domain name Registrars offer a "privacy" or "proxy" service to mask the domain name owner. This domain is most likely using a proxy service. |
